InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Invivyd, Inc.

IVVD Clue Score60
United States Fiscal year ends December CIK 0001832038 Results filed 13 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

21
Insider
Date
Role
Action
Shares
Price
Amount
Robert D. Allen III
18 Aug 2026
Chief Scientific Officer
Sold on a plan
17,043
$0.84
$14.37K
Jill Andersen
18 Aug 2026
Chief Legal Officer, Secretary
Sold on a plan
30,706
$0.84
$25.88K
William E. Duke
18 Aug 2026
Chief Financial Officer
Sold on a plan
18,425
$0.84
$15.53K
Julie Green
18 Aug 2026
Chief Human Resources Officer
Sold on a plan
18,425
$0.84
$15.53K
Timothy Edward Lee
18 Aug 2026
Chief Commercial Officer
Sold on a plan
18,425
$0.84
$15.53K
Robert D. Allen III
17 Aug 2026
Chief Scientific Officer
Sold on a plan
20,679
$0.72
$14.93K
Jill Andersen
17 Aug 2026
Chief Legal Officer, Secretary
Sold on a plan
37,256
$0.72
$26.90K
William E. Duke
17 Aug 2026
Chief Financial Officer
Sold on a plan
22,355
$0.72
$16.14K
Julie Green
17 Aug 2026
Chief Human Resources Officer
Sold on a plan
22,355
$0.72
$16.14K
Timothy Edward Lee
17 Aug 2026
Chief Commercial Officer
Sold on a plan
22,355
$0.72
$16.14K
Jill Andersen
18 Feb 2026
Chief Legal Officer, Secretary
Sold on a plan
34,939
$1.58
$55.13K
Timothy Edward Lee
18 Feb 2026
Chief Commercial Officer
Sold on a plan
20,964
$1.58
$33.08K
William E. Duke
18 Feb 2026
Chief Financial Officer
Sold on a plan
20,964
$1.58
$33.08K
Julie Green
18 Feb 2026
Chief Human Resources Officer
Sold on a plan
20,964
$1.58
$33.08K
Robert D. Allen III
18 Feb 2026
Chief Scientific Officer
Sold on a plan
19,392
$1.58
$30.60K
Jill Andersen
17 Feb 2026
Chief Legal Officer, Secretary
Sold on a plan
32,771
$1.54
$50.45K
Timothy Edward Lee
17 Feb 2026
Chief Commercial Officer
Sold on a plan
19,663
$1.54
$30.27K
William E. Duke
17 Feb 2026
Chief Financial Officer
Sold on a plan
19,663
$1.54
$30.27K
Julie Green
17 Feb 2026
Chief Human Resources Officer
Sold on a plan
19,663
$1.54
$30.27K
Robert D. Allen III
17 Feb 2026
Chief Scientific Officer
Sold on a plan
18,189
$1.54
$28.00K
Kevin F McLaughlin
19 Nov 2025
Director
Buy
50,000
$2.50
$125.00K

What was left out

Form 4 filings counted 25
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 20
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 1,139,000
History held since 9 Aug 2021